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The precise impact of thymic positive and negative
selection on the T cell receptor (TCR) repertoire re-
mains controversial. Here, we used unbiased, high-
throughput cloning and retroviral expression of
individual pre-selection TCRs to provide a direct
assessment of these processes at the clonal level
in vivo. We found that 15% of random TCRs induced
signaling and directed positive (7.5%) or negative
(7.5%) selection, depending on strength of signal,
whereas the remaining 85% failed to induce signaling
or selection. Most negatively selected TCRs ex-
hibited promiscuous crossreactivity toward multiple
other major histocompatibility complex (MHC)
haplotypes. In contrast, TCRs that were positively
selected or non-selected were minimally crossreac-
tive. Negative selection of crossreactive TCRs led
to clonal deletion but also recycling into intestinal
CD4CD8b intraepithelial lymphocytes (iIELs).
Thus, broadly crossreactive TCRs arise at low fre-
quency in the pre-selection repertoire but constitute
the primary drivers of thymic negative selection and
iIEL lineage differentiation.
INTRODUCTION
Although the importance of thymic selection in establishing a
tolerant and functional T cell receptor (TCR) repertoire has
been recognized for more than three decades, the precise role
and relative importance of positive and negative selection are
still widely debated (Klein et al., 2014; Vrisekoop et al., 2014).
Double-positive (DP) and single-positive (SP) thymocyte turn-
over kinetics suggest that approximately 95% of DP thymocytes
fail to produce SP progeny, indicating that positively selected
TCRs represent only a minor fraction of the pre-selection reper-
toire (Scollay et al., 1980). Although an early study examining
apoptosis in major histocompatibility complex (MHC) class I
and MHC class II double-deficient (MHC-deficient; B2m/H2-
Ab1/) thymuses suggested that very few thymocytes areInegatively selected (Surh and Sprent, 1994), recent studies
have shown that sizeable frequencies of thymocytes with
elevated TCR signaling, marked by Nur77 and Helios (canonical
activation markers), are rescued from cell death in mice lacking
the pro-apoptotic molecule Bim, a key mediator of negative se-
lection (Daley et al., 2013; Stritesky et al., 2013). These and other
studies also indicate that negative selection could occur in both
the cortex and medulla in response to MHC ligands expressed
by a variety of cell types including dendritic cells as well as
cortical and medullary epithelial cells (reviewed in Klein et al.,
2014). Furthermore, although negative selection is traditionally
envisioned as deletion of self-peptide-specific T cells, it is also
suggested to eliminate MHC-crossreactive TCRs that might
arise as a consequence of a germline-encoded bias of TCRs
for recognition of MHC (Huseby et al., 2005). Together, these
findings suggest that negative selection might be more common
than initially suspected and that negatively selecting TCRs might
constitute a substantial fraction of selected cells. However, the
relative frequencies of positive and negative selection remain un-
clear and global estimates of negative selection range widely be-
tween 3% and 30% of the TCR repertoire (Daley et al., 2013;
Laufer et al., 1996; Merkenschlager et al., 1997; Stritesky et al.,
2013; van Meerwijk et al., 1997).
Few studies have examined the pre-selection TCR repertoire.
Analysis of reaggregate thymic organ cultures where MHC-defi-
cient thymocytes are added to MHC class I- and MHC class II-
expressing stroma reveal that 15%–20% of pre-selection DP
thymocytes can interact with self-MHC:peptide, but this experi-
mental system can not distinguish between positive selection
and negative selection (Merkenschlager et al., 1997). A single
study has examined the pre-selection TCR repertoire at the
clonal level by maturing MHC-deficient DP thymocytes in vitro
with anti-CD3 and anti-CD4 antibodies to generate CD4+ hybrid-
omas and has found that only 5% of pre-selection TCRs can
react against a given MHC class II haplotype in vitro and that
30% react against at least one of a panel of eight MHC haplo-
types (Zerrahn et al., 1997). These data suggest that negative se-
lection is rare and that the pre-selection TCR repertoire is
broadly MHC reactive. Notably, this study detected few cross-
reactive TCRs, suggesting that crossreactivity is rare in the
pre-selection repertoire and that the previously observed accu-
mulation of crossreactive TCRs in MHC:single peptide mice is
due to both impaired negative selection and extreme bias inmmunity 43, 859–869, November 17, 2015 ª2015 Elsevier Inc. 859
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positive selection (Barton and Rudensky, 1999; Grubin et al.,
1997; Huseby et al., 2005; Sant’Angelo et al., 1997; Surh et al.,
1997; Tourne et al., 1997). Importantly, an unbiased clonal
assessment of the pre-selection repertoire has not been per-
formed in vivo and the true frequencies of positive selection,
negative selection, and MHC crossreactivity remain elusive.
Here, we have performed a high-throughput, unbiased clonal
screen of random TCRab pairs that had not been previously sub-
mitted to selection. More than 80 random individual TCRs were
expressed retrovirally in thymocytes using a conditional system
for appropriate timing of expression of the TCRa chain and a
mixed chimeric setting to ensure representation of a polyclonal
repertoire side by side with the clonal TCR. In this system,
thymocyte signaling and development could be reliably charac-
terized in vivo, allowing for a direct assessment of thymic selec-
tion processes at the clonal level and on a large scale. We found
that 7.5% of pre-selection TCRs were positively selected,
whereas 7.5%were autoreactive and negatively selected. Nega-
tive selection occurred predominantly at the DP stage and the
DP-SP transition and, less frequently, at the medullary SP stage.
Unlike classic MHC:peptide-specific T cells, a majority of these
autoreactive TCRs were crossreactive against multiple MHC
haplotypes and across MHC classes. Although negative selec-
tion induced massive clonal deletion, a fraction of cells consis-
tently escaped deletion and were recycled into intestinal intrae-
pithelial lymphocytes (iIELs). These findings reconcile previous
conflicting reports by showing that negative selection is rare
compared with the size of the pre-selection repertoire but never-
theless predominantly targets crossreactive TCRs. Altogether,
these data have major implications for our understanding of cen-
tral tolerance, highlighting MHC crossreactivity as a crucial
target of negative selection and driver of innate iIEL lineage
differentiation.
RESULTS
Thymic Selection Was Modeled In Vivo via a Conditional
Retroviral TCR Expression System
To facilitate the clonal analysis of TCRs from the pre-selection
repertoire, we made use of mice expressing one of four
different TCRb transgenes (Table S1). In each of these lines,
TCR diversity was restricted to the TCRa chain, allowing
normal positive selection and negative selection, as judged
by normal frequencies of TCRhiCD69+PD-1lo thymocytes and
TCRhiCD69+PD-1hi thymocytes, respectively, and by normal
frequencies of all TCRab+ cell lineages including CD4+ and
CD8+ T cells, regulatory T (Treg) cells (TCRhiCD4+Foxp3+),
and unconventional iIELs (CD4CD8bTCRab+) (Figures S1A–Figure 1. Expression of Pre-selection TCRs
(A) Pre-selection DP thymocytes were sorted from MHC-deficient or Trac/ m
retroviral vector, as diagrammed. TCRa RVcond contains a loxP-flanked GFP, th
excision of the upstream GFP sequence can the TCRa chain be translated. Bon
RVcond and mixed with control CD45.1-congenic WT bone marrow transduced w
recipient.
(B) Representative flow cytometry of the thymus and spleen of mixed RV chimera
observed. All plots are pre-gated on transduced (Thy1.1+) CD45.2 cells. The TC
expressed in a given chimera. Abbreviations are as follows: No Sel, no selection; P
TCR can be found in Table S1 and additional controls in Figures S1 and S2. Data s
subsequent figures.
IS1D; McDonald et al., 2014). Even when analysis was limited
to Vb-transgenic T cells expressing a given Va family such as
Va2 or Va8, a close approximation of the wild-type frequency
of these lineages was observed. As expected, most TCRVb
and TCRVa chains examined in this study paired efficiently
and could be detected at the cell surface, with the exception
of the Vb8.3/Va2 combination (Figure S1B and data not shown;
Blackman et al., 1986).
To model the broad pre-selection repertoire, we cloned large
numbers of Trav14 (TCRVa2) and Trav12 (TCRVa8) chains from
pre-selection DP thymocytes purified from either MHC-deficient
or Trac/ mice. We then used a conditional retroviral system to
transduce these TCRa chains into bone marrow cells of
TCRVb-transgenic Cd4-cre mice and subsequently reconsti-
tuted lethally irradiated CD45.1 congenic recipients (Figure 1A
and Table S1). This Cd4-cre conditional system closely mimics
the physiological kinetics and amounts of TCR expression (Fig-
ures S2A and S2B; McDonald et al., 2014). In many cases, to
avoid expression of endogenous Va chains, the transduced
bone marrow cells also harbored a Trac/ mutation. Trans-
duced cells could be identified by expression of vector-encoded
Thy1.1 and antibodies against Va2 or Va8. Finally, in all cases,
control CD45.1 bone marrow cells transduced with the empty
vector (lacking the Va sequence) were coinjected to obtain
mixed bone marrow chimeras where T cells expressing the
TCR under study represented 1%–60% of all T cells and a
normal polyclonal T cell environment was preserved.
By combinatorial pairing of the four Vb transgenes with these
randomVa2 and Va8 chains, we obtained 81 pre-selection TCRs
(Table S1).
Most TCRsCloned from the Pre-selection Pool Fail to Be
Selected
As expected, we found TCRs that fell into three main categories.
Many TCRs were developmentally arrested at the DP stage with
a lack of apparent selection. These TCRs represented 69 of 81
pre-selection TCRs, corresponding to 85% of the pre-selection
repertoire. These non-selected TCRs characteristically induced
a uniform DPhi phenotype, without expression of markers of
TCR signaling such as CD69 or PD-1, low amounts of CD5,
and an absence of mature peripheral T cells. One prototypical
example is given in Figure 1B, as Vb7Va8-82, and a summary
shown in Figures 2A (top), 2C, and 2D.
Other TCRs (n = 6; 7.5% of the pre-selection repertoire) gave a
typical pattern of positive selection, with induction of CD69 at the
DP stage, upregulation of CD5, and generation of either CD4+ or
CD8+ SP thymocytes expressing the CCR7 chemokine receptor
associated with migration into the medulla. These cellsice as shown, and TCRa chains were cloned and inserted into a conditional
e TCRa chain of interest, and an IRES-Thy1.1. Only after Cd4-Cre-mediated
e marrow from TCRVb transgenic Cd4-Cre mice was transduced with TCRa
ith Empty RVcond, before injection into a lethally irradiated, CD45.1-congenic
s, gated as indicated, demonstrating the different types of selection outcomes
Rhi gate was determined with antibodies specific for the relevant Vb and Va
S, positive selection; NS, negative selection. Additional information about each
hown are representative of more than 100 independent chimeras as detailed in
mmunity 43, 859–869, November 17, 2015 ª2015 Elsevier Inc. 861
Figure 2. Frequencies of Positive Selection, Negative Selection, and No Selection Outcomes for Pre-selection and Post-selection DP CD69+
TCRs
(A) Summary of outcomes.
(B) Flow cytometry of thymus and spleen from a TCR identified as inducing medullary rather than cortical negative selection.
(C and D) Summary of all 92 pre-selection and post-selection (DP CD69+) TCRs analyzed in RV chimeras. CD5 and PD-1 expression are presented relative to
control amounts in CD69 DPs. Cell numbers were normalized based on the frequency of transduction in splenic non-T cells. Open and filled circles denote
chimeras constructed from Trac+/ and Trac/ bone marrow, respectively.
(E) The numbers of thymocytes were normalized as in (C) and (D).
(F) TCRa amino acid sequences from TCRs scored as no selection, positive selection, or negative selection were compared with a reference pool of TCRa
sequences derived from Vb-only transgenic splenocytes, to determine the frequency of overlap.
p values were calculated by Student’s t test. Data pooled from 20 independent experiments.expressed variable but generally low amounts of PD-1. This pos-
itive selection pattern is exemplified in Figure 1B, by Vb8.2Va8-
80 and Vb3Va8-82, which gave rise to CD4+ and CD8+ lineage
T cells, respectively, and is summarized in Figures 2A (top),
2C, and 2D.862 Immunity 43, 859–869, November 17, 2015 ª2015 Elsevier Inc.Finally, we detected TCRs inducing negative selection (n = 6;
7.5% of the pre-selection repertoire). All of these TCRs gave
a CD5hiCD69hiDPlo phenotype associated with very high
amounts of PD-1. They generated very few splenic T cells, which
were mostly of the CD4CD8blo/ phenotype, but abundant
unconventional iIELs with a similar CD4CD8blo/ phenotype
(Figure 1B, Vb8.2Va8-72 and data not shown). These data
confirm and extend results from our previous study of iIELs
andDPloPD-1hi TCRs (McDonald et al., 2014). Notably, the nega-
tively selected thymocytes did not express CCR7, which is nor-
mally induced by positive selection and directs migration to the
medulla, suggesting that they had received negative selection
signals in the cortex (Figure 1B).
The phenotypes of all 81 pre-selection TCRs are summarized
in Figures 2A (top), 2C, and 2D.
Positive and Negative Selection Occur at Similar
Frequencies
We found that an equal frequency of pre-selection TCRs under-
went positive selection or negative selection. Because only a
small fraction of pre-selection TCRs (15%) were selected, there
were only 12 such TCRs in our pool of 81 pre-selection TCRs.
Therefore, to increase the size of this panel and further probe
the relative frequencies of positive selection and negative selec-
tion, we purified post-selection CD69+ DP thymocytes from Vb7
or Vb8.2 transgenic mice and cloned their Trav14 and Trav12
chains. The post-selection (DP CD69+) phenotype represents
cortical thymocytes that have recently received a selection
signal, either for positive selection or negative selection. Retro-
viral expression of ten of these TCRa chains in corresponding
Vb-transgenics revealed that five TCRs induced negative selec-
tion, whereas five induced positive selection (Figure 2A, bottom).
Thus, positive selection and negative selection appear to occur
at equal frequencies among selected TCRs.
One of these post-selection (DP CD69+)-derived TCRs,
Vb8.2Va2-132, induced a pattern suggestive of medullary rather
than cortical stage negative selection, based on expression of
CCR7 and CD69 in SP CD8 thymocytes, along with Helios
(data not shown), and lack of peripheral T cells (Figure 2B).
This pattern of late negative selection, which has been reported
previously (Daley et al., 2013), appeared to represent a relative
minority of total negative selection (1 out of 12).
A compilation of outcomes for all pre-selection- and post-se-
lection (DP CD69+)-derived TCRs is presented in Figures 2A and
2C–2E. Altogether, the results indicate that 85% of TCRs failed
to be selected, whereas 7.5% were positively selected and
7.5% were negatively selected.
Several observations and additional controls suggest that our
method of TCR expression faithfully reports the fate of individual
TCRs. First, our previously published experiments using a similar
expression system have shown that, in all cases, TCRs extracted
from peripheral T cell lineages faithfully reproduced their lineage
of origin upon transgenic expression (McDonald et al., 2014).
Second, of 11 TCRs cloned from post-selection (DP CD69+) thy-
mocytes, which represent thymocytes that have been signaled
by MHC ligands in vivo, a great majority (10 of 11) induced a
pattern of positive selection or negative selection in the condi-
tional retrogenic chimeras (Figure 2A [bottom] and Table S1),
as expected. Third, negative selection TCRs tended to be asso-
ciated with a smaller thymus, highlighting their deletional pheno-
type (Figure 2E). Finally, we found that up to 38% of the TCRa
chains that induced positive selection in our study could also
be found among a reference pool of 500 sequences indepen-
dently derived from two TCRVb-only transgenic spleens. InIcontrast, only 2% of the non-selected TCR sequences and 0%
of the negative selection TCR sequences could be found in this
reference pool (Figure 2F).
The Negative Selection Repertoire Is Enriched in MHC
Multi-reactive TCRs
To assess the MHC reactivity of individual TCRs, we purified un-
signaled DP thymocytes from RV chimeras based on their
CD69PD-1 DP phenotype and cultured them with stimulator
cells expressing different MHC haplotypes, including mixtures
of allogeneic thymocytes and splenocytes (expressing both
MHC I and II) as well as a panel of SV40-transformed fibroblasts
(expressing only MHC I) from different strains. In this system,
TCRs were tested at the relevant DP differentiation stage
together with both coreceptors, ensuring physiologically rele-
vant responses against both classes of MHC. As shown in Fig-
ure 3A, the non-selected Vb8.2Va8-75 TCR showed no induction
of CD69 and PD-1 above background represented by B6 MHC-
deficient stimulators. In contrast, the negatively selected TCR
Vb8.2Va2-20 reacted strongly against many different stimula-
tors, including H2b,d,k,r,u,q, a very unusual pattern of multi-cross-
reactivity similar to the one described in MHC:single peptide
mice (Huseby et al., 2005). We confirmed the reactivity of
Vb8.2Va2-20 against the ‘‘d’’ haplotype by expressing this TCR
directly on the B10.D2 background. As shown in Figure 3B,
Vb8.2Va2-20-expressing thymocytes were arrested at a
DPloPD-1hi stage and gave rise to only rare DN splenocytes
and to unconventional CD4CD8b iIELs in both B6 and
B10.D2 backgrounds, a pattern typical of negative selection
TCRs.
To further assess the relationship between MHC crossreactiv-
ity and T cell fate, we extended our in vitro analysis to a total of 83
TCRs drawn predominantly from the non-selected, positive se-
lection, and negative selection panels described previously,
but also from other populations as described in Table S1.
Notably, we found that most but not all negative selection
TCRs exhibited a pattern of crossreactivity similar to
Vb8.2Va2-20 (Figure 4A), with a total of 61 reactivities for 21
TCRs. In contrast, none of the 15 positive-selection TCRs ex-
hibited the crossreactive pattern, and only a total of 7 MHC
reactivities were detected (Figure 4B). Likewise, out of 47
non-selected TCRs, only 12 MHC reactivities were detected
(Figure 4C). Thus, there is a massive enrichment of MHC cross-
reactive TCRs in the negative selection pool (Figure 4D). Impor-
tantly, however, 6 out of the 21 negative-selection TCRs did not
show a crossreactive pattern, suggesting that they might repre-
sent classical MHC:peptide-specific autoreactive TCRs.
We further determined whether these crossreactive TCRs
could react against bothMHC I andMHC II in the C57BL/6 back-
ground by using MHC I-, MHC II-, and MHC I and II-deficient B6
stimulators in vitro or by expressing TCRs in correspondingMHC
I-, MHC II-, and MHC I and II-deficient mice in vivo. In addition to
recognizing multiple MHC haplotypes, one-third of negative-se-
lection TCRs also exhibited dual reactivity to MHC class I and
class II, as summarized in Figure 5D. Representative examples
are shown in vitro (Figure 5A) with Vb8.2Va2-107 responding to
MHC I, Vb8.2Va2-110 to MHC II, and Vb7Va2-U4 responding
to both classes of MHC. This in vitro reactivity was further vali-
dated in vivo for a subset of TCRs where self MHC reactivitymmunity 43, 859–869, November 17, 2015 ª2015 Elsevier Inc. 863
Figure 3. Identification of MHC Crossreactive TCRs
(A) Unsignaled CD69PD-1 DP thymocytes from no selection TCR Vb8.2Va8-75 or negative selection TCR Vb8.2Va2-20 were cultured with a mixture of mouse
thymocytes and splenocytes or with SV-40 transformed fibroblasts derived from indicated strains of variousMHC haplotypes prior to staining for CD69 and PD-1.
Black boxes highlight MHC-reactive TCRs.
(B) Flow cytometry of Vb8.2Va2-20 expressing cells in B6 (H2b) or B10.D2 (H2d) backgrounds. Similar in vivo results were obtained with three out of three
additional TCRs rective against the H2b or H2d backgrounds in vitro.could be confirmed by characteristic abundance of CD69+
DPloPD-1hi thymocytes (Figures 5B and 5C). Thus, the negative
selection repertoire is uniquely enriched in TCRs that exhibit
prominent alloreactivity as well as MHC class I and II dual
reactivity.
Negative Selection at the DP Stage Requires Store-
Operated Calcium Entry
DPloPD-1hi thymocytes have been previously suggested to un-
dergo negative selection based on higher induction of Nur77,
Helios, and Egr2 downstream of TCR signaling, caspase 3 acti-
vation, annexin-V staining, and rescue by Bim deficiency or Bcl-
xL overexpression. However, although recent experiments sug-
gest that store-operated calcium entry (SOCE) is required for the
generation of unconventional iIELs along with the other agonist-
signaled NKT and Treg cell lineages (Oh-Hora et al., 2013), the
requirement of SOCE for the generation of TCRbhiDPloPD-1hi
thymocytes undergoing negative selection, which are the thymic
precursors to iIELs, has not been directly tested. By analysis of
mice with conditional deletion of Stim1 and Stim2 in hematopoi-
etic cells, we found that the TCRbhiDPloPD-1hi phenotype was
absolutely dependent on SOCE, even in mixed WT:Vav-icre
Stim1fl/flStim2fl/fl chimeras, establishing the cell-intrinsic require-
ment of SOCE for negative selection at the DP stage (Figures 6A–
6C). In contrast, as previously reported, positive selection of
conventional TCRbhiPD-1loCD4+ and CD8+ T cells was unper-
turbed (Figures 6A–6C). Furthermore, upon stimulation of
CD69 DP thymocytes with anti-TCRb antibody and dendritic
cells in vitro, SOCE was also required for efficient downregula-
tion of CD4 and CD8 as well as for expression of PD-1 (Fig-
ure 6D). Thus, these results further establish the peculiar agonist864 Immunity 43, 859–869, November 17, 2015 ª2015 Elsevier Inc.signaling pathway required for negative selection of self-reactive
DP thymocytes and explain the absence of iIELs in Stim1 and 2
double-deficient mice.
DISCUSSION
Here, we took advantage of an improved retroviral method of
expression of TCRs to perform a large-scale study of pre-selec-
tion TCRs at the clonal level in vivo in conditions that preserved
physiological aspects of thymic development, such as normal ki-
netics and amounts of TCR expression, as well as a polyclonal
environment. By determining both the level of signaling and the
corresponding fate of thymocytes for individual TCRs, we
derived a direct, unbiased estimate of the rates at which thymo-
cytes undergo positive selection (7.5%) and negative selection
(7.5%). Furthermore, by performing a detailed analysis of the
pattern of MHC reactivity for large numbers of randomTCRs cor-
responding to pre- and post-selection stages, we resolved a
longstanding controversy regarding the true impact of negative
selection on the TCR repertoire and the frequency of crossreac-
tive TCRs.
TCRs showing a highly unusual pattern of MHC crossreactivity
have been occasionally reported in mouse and human T cell
clones, but were consistently found at high frequency inmice ex-
pressing a single MHC:peptide complex (Huseby et al., 2005;
Logunova et al., 2005). These crossreactive TCRs lacked the de-
gree of specificity for peptide and MHC that is the hallmark of
most classical antigen-specific T cells. Instead, they had promis-
cuous specificity for various MHC and peptide ligands. One
group hypothesized that crossreactive TCRs illustrated the
inherent, germline-encoded bias of TCRs for binding MHC
Figure 4. Most Negative Selection TCRs Are
MHC Crossreactive
(A–C) TCRs are listed and classified according to
their negative selection (A), positive selection (B),
or no selection (C) phenotype, determined as in
Figure 3A, with filled box denoting reactivity
against corresponding MHC expressed by a
mixture of splenic and thymic cells, or by a panel of
SV40-transformed fibroblasts as in Figure 3. MHC
reactivity was defined by induction of greater than
10% increase in CD69+PD-1+ cells over MHC-
deficient stimulator cells. Most TCRswere from the
pre-selection pool, but some TCRs obtained from
iIELs or post-selection (CD69+) pools (as listed in
Table S1) were added to increase the size of the
positive selection and negative selection TCR
collections.
(D) Summary of MHC crossreactivity for TCRs of
each group. p values were calculated by Mann-
Whitney test. Data pooled from 15 independent
experiments.molecules and predicted that they represent a large fraction of
the pre-selection repertoire (Huseby et al., 2005). In this view, a
critical function of negative selection, in addition to self-toler-
ance, was to create an MHC- and peptide-specific repertoire
by removing crossreactive TCRs. Contrasting with this view, a
study of CD4+ hybridomas derived from MHC-deficient pre-se-
lection thymocytes reported that crossreactivity was very rare
and occurred to a similar extent in the pre-selection and MHC-
selected repertoires (Zerrahn et al., 1997). This study implies
that the high frequency of crossreactive TCRs reported in
MHC:single peptide mice must have resulted from their aberrant
accumulation due to both biased positive selection and impaired
negative selection. Here, by focusing our study on a large num-
ber of pre-selection TCRs, as well as a large group of random
TCRs inducing negative selection, we found that crossreactivity
was very infrequent among pre-selection TCRs overall, whereas
an overwhelming majority (71%) of TCRs associated with nega-
tive selection were crossreactive. Furthermore, the crossreac-
tive TCRs could be observed in multiple Va/Vb combinations.
These results reconcile the two opposing models by showing
that, as shown in the pre-selection hybridoma panel study (Zer-
rahn et al., 1997), the frequency of crossreactive TCRs is indeed
very low in the pre-selection repertoire, whereas, as suggested
from the MHC:single peptide studies (Huseby et al., 2005),Immunity 43, 859–869, Ncrossreactive TCRs can be found at high
frequency among normal unbiased nega-
tive selection thymocytes. Although our
results were established across four
different Vb transgenic chains, including
Vb8.2, which is overrepresented in the
natural repertoire, and two different fam-
ilies of Va, we cannot exclude the possi-
bility that certain Vb or Va might be more
or less biased toward crossreactivity, a
subject of further studies.
Our finding that positive selection and
negative selection occurred at a similar
rate implies that half of the TCRs beingsignaled in the thymic environment are autoreactive, empha-
sizing the major impact of thymic-negative selection in shaping
the TCR repertoire. However, this impact seems mostly due to
the high relative frequency of crossreactive TCRs rather than
classical MHC:peptide specificity. In addition, TCRs sharing
the same TCRb chain and differing only by a few amino acid res-
idues in their CDR3a regions could nevertheless exhibit drasti-
cally different patterns of thymic selection and MHC reactivity,
consistent with the proposition that the germline-encoded TCR
bias for MHC is encoded in the CDR1 and CDR2 regions,
whereas hypervariable CDR3 loops determine the outcome of
allele-specific selection (Garcia et al., 2009).
The finding that negative selection thymocytes predominantly
express crossreactive TCRs is also consistent with the fact that
signaling for negative selection seems to be predominantly
induced in the cortex or at the junction between cortex and me-
dulla, as indicated by theDPloPD-1hiCCR7 phenotype of a great
majority of thymocytes undergoing negative selection. Indeed, a
promiscuous self-reactive TCR is likely to be detected early by
dendritic cells or epithelial cells in the cortex whereas, in
contrast, specific recognition of tissue-restricted antigens is
more likely to operate in the medulla. In that respect, although
this study did not address the pattern of MHC and peptide spec-
ificity of natural Treg cells, it is interesting to consider thatovember 17, 2015 ª2015 Elsevier Inc. 865
Figure 5. Crossreactive TCRs Are Frequently Reactive against Both MHC Class I and II
(A) Unsignaled CD69PD-1 DP thymocytes purified from the indicated retrogenic mice were cultured with stimulator cells derived from either WT or various
MHC-deficient mouse strains in the B6 background to determine the relative increase in CD69+PD-1+ cells. Representative TCRs are shown.
(B and C) In vivo validation by examining thymocyte development in MHC I-deficient, MHC II-deficient, or MHC-deficient backgrounds for Vb8.2Va2-107 (B) and
for Vb7Va2-U4 (C). In total, we confirmed the expected MHC reactivity in vivo for four out of four different TCRs.
(D) Summary of MHC class I and class II reactivities for 19 negative selection TCRs. Data are pooled from eight independent experiments.differences might exist between Aire-dependent TCRs, which
are expected to be MHC and peptide specific, and other Treg
cells, for which promiscuous recognition of self-ligands might
be advantageous. Future experiments should be designed to
answer this important question.
Although there have been various estimates of the frequency
of negative selection induced by antigen recognition in the me-
dulla, most studies have relied on indirect assessments or trans-
genic systems. Our results suggest that relatively few TCRs un-
dergo negative selection at that late stage of differentiation,
although it remains possible that, similar to reports on Treg cell
differentiation (Bautista et al., 2009; Leung et al., 2009), cell-
extrinsic factors might limit medullary negative selection against
a particular antigen.866 Immunity 43, 859–869, November 17, 2015 ª2015 Elsevier Inc.Finally, it is noteworthy to consider that negative selection is
not synonymous with clonal deletion, as shown by the fact that
a fraction of negative selection TCRs are recycled into
CD4CD8b iIELs (McDonald et al., 2014; Pobezinsky et al.,
2012). We previously found that TCRs cloned from these iIELs
invariably give rise to DPloPD-1hi thymocytes bearing the hall-
marks of elevated TCR signaling, and conversely, TCRs cloned
fromDPloPD-1hi thymocytes give rise exclusively to CD4CD8b
iIELs. Here, we further extended these tight correlations with
random pre-selection TCRs and formally demonstrated a
selective requirement for agonist signaling in the formation of
DPloPD-1hi thymocytes, as shown by their selective dependence
on SOCE proteins Stim1 and Stim2, similar to NKT and Treg cell
thymocytes (Oh-Hora et al., 2013). Because the iIEL TCRs are
Figure 6. Cortical Negative Selection Requires Store-Operated Calcium Entry
(A) Flow cytometry analysis of thymus from Vav-icre Stim1fl/flStim2fl/fl (dKO) and littermate control mice gated as indicated.
(B) Flow cytometry analysis of mixed bone marrow chimeras composed of a 1:1 mixture of WT (CD45.1) and Vav-iCre Stim1fl/flStim2fl/fl (CD45.2) cells.
(C) Summary plots with data points pooled from experiments using WT and dKO mice (black circles), mixed bone marrow chimeras (gray filled circles), and non-
competitive bone marrow chimeras (open circles).
(D) Left: Flow cytometry analysis of sorted DP CD69 thymocytes from mice of the indicated genotypes stimulated for 18 hr with plate-bound anti-TCRb + DCs.
Right: Summary plots.
p values were calculated by Student’s t test. Data pooled from four experiments (C) or two experiments (D).broadly crossreactive, we speculate that, similar to NK recep-
tors, they might function like innate-like receptors sensing
MHC ligands rather than specific peptides in the intestinal envi-
ronment. Conversely, the finding that crossreactive TCRs repre-
sent a prominent population of autoreactive TCRs warrants
close consideration of their role in autoimmune diseases.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6, BALB/c, C3H, B10.D2 (B10.D2-Hc1 H2d H2-T18c/nSnJ), B10.BR
(B10.BR-H2k2 H2-T18a/SgSnJJrep), Trac/ (B6.129S2-Tcratm1Mom/J),
B2m/ (B6.129P2-B2mtm1Unc), and CD45.1 (B6.SJL-Ptprca Pep3b/BoyJ)
mice were from Jackson Laboratories. Cd4-cre (B6.Cg-Tg(Cd4-cre)1Cwi),
H2-Kb/H2-Db/ (B6.129P2-H2-Kbtm1H2-Dbtm1),H2-Ab1/ (B6.SJL(129)-
Ptprca/BoyAiTac H2-Ab1tm1Gru), and B2m/H2-Ab1/ (MHC-deficient)
(B6.129-H2-Ab1tm1Gru B2mtm1Jae N17) mice were from Taconic. TCR Vb3,
Vb7, Vb8.2, Vb8.3, Vb7 U1 Tgcond, and Vb7 U4 Tgcond transgenic mice were
previously described and maintained in our colony (Malchow et al., 2013;
McDonald et al., 2014; Savage et al., 2008, 2011). Vav-icre Stim1fl/flStim2fl/fl
mice were previously described and maintained at Kyushu University (Oh-IHora et al., 2013). All mice were maintained in a specific-pathogen-free envi-
ronment at either the University of Chicago or Kyushu University and experi-
ments were performed in accordance with the guidelines of the Institutional
Animal Care and Use Committees.
Cell Isolation
Single-cell suspensions of thymocytes and splenocytes were obtained by me-
chanical disruption of the tissue through a 70-mm cell strainer. Small intestines
were excised from mice and fat, Peyer’s patches, and luminal contents
removed. The intestine was opened longitudinally and cut into 1 cm pieces.
Pieces were stirred with a magnetic stirrer for 2 hr in RPMI-10% FCS and
then purified by running over a glass-wool column (Fisher Science France) fol-
lowed by centrifugation on 40% percoll (Sigma) to further remove epithelial
cells and debris.
Retrovirus Production, Infection, and Chimera Generation
Trav14 and Trav12 chains were PCR cloned from cDNA derived from FACS-
sorted pre-selection (DP CD69) or selected (CD4+CD69+, DP CD69+, total
CD69+, or DPloPD-1hi) thymocytes as listed in Table S1. The Trac chain genes
were inserted into a conditional retroviral vector, pMGflThy1.1, as described
below (McDonald et al., 2014; Turner et al., 2010). Recombined Trav14 or
Trav12 gene segments and the Trac constant region were PCR amplified usingmmunity 43, 859–869, November 17, 2015 ª2015 Elsevier Inc. 867
Q5 DNA polymerase (New England Biolabs) with 5% DMSO. PCR products
were gel purified using a QIAquick Gel Extraction Kit (QIAGEN). Purified
Trav14 or Trav12 and TRAC products were assembled together with NotI-
and AgeI-digested pMGflThy1.1 using Gibson Assembly Master Mix (New En-
gland Biolabs). Assembled product was transformed into XL10 Gold ultracom-
petent cells (Agilent) andplasmidscarrying thecorrect insertwerepurifiedusing
the HiSpeed Midi Prep kit (QIAGEN). Plasmid preparations were sequenced to
verify the TCR insert. Constructs were transfected into Plat-E packaging cells
using lipofectamine (Life Technologies) (Morita et al., 2000).Harvested retroviral
supernatant was filtered through a 0.45 mm filter and frozen in a dry ice and
ethanol bath. TCR Vb3, Vb7, Vb8.2, or Vb8.3 transgenic Cd4-cremice (Trac/
or Trac+/+) were injected with 150 mg kg1 5-Fluorouracil (APP Pharmaceuti-
cals) 3 days prior to bone marrow harvest. After harvest, bone marrow was
cultured for 2 days in X-Vivo 10 medium (Lonza) supplemented with 15%
FCS, 1% penicillin and streptomycin, 100 ng ml1 mouse SCF, 10 ng ml1
mouse IL-3, and 20 ng ml1 human IL-6 (all from Biolegend). Stimulated cells
were infectedwith TCRa-encoding retrovirus in the presence of 4 mgml1 poly-
brene (EMDMillipore) by centrifugation at 8003 g for 90 min at 30C. After 20–
24 hr of additional culture in medium as above, bonemarrow cells were stained
with an antibody against mouse thy1.1 andMACS enriched (Miltenyi Biotec). In
order to enable side-by-side comparison between a particular TCRa chain and
apolyclonalwild-type repertoire,wild-typeCD45.1micewere treatedas above,
but instead infectedwithempty (lackingTCRa-coding sequences) pMGflThy1.1
and MACS enriched. For experiments designed to confirm TCRmultireactivity,
wild-type B10.D2 or B10.BR mice were treated as above, but instead infected
with empty pMGfl4 (lacking TCR-a and encoding a signaling-deficient human
CD4 protein) and MACS enriched. Recipient mice were lethally irradiated with
1,000 rads from a gamma cell 40 irradiator with a cesium source. At least 4 hr
after irradiation, recipients were injected with a 1:1 mixture of WT to TCR trans-
ducedVb-transgenicbonemarrow.Chimericmicewereanalyzed4–6weeksaf-
ter reconstitution. We confirmed proper expression of the transduced TCRa
chains by staining thymocytes with antibody specific for Va2 or Va8.
Antibodies and Flow Cytometry
Purified cell populations were incubated with Fc Block (Biolegend or BD)
prior to FACS staining. Fluorochrome- or biotin-conjugated monoclonal anti-
bodies (clone in parentheses) against mouse CCR7 (4B12), CD4 (GK1.5 or
RM4-5), CD5 (53-7.3), CD8a (53-6.7), CD8b (53-5.8), CD45.1 (A20), CD45.2
(104), CD69 (H1.2F3), Foxp3 (FJK16s), PD-1 (29F.1A12), TCRb (H57-597),
Thy1.1 (OX-7), Va2 (B20.1), Va8 (KT50), Vb3 (KJ25), Vb7 (TR310), Vb8.2
(KJ16-133.18), Vb8.3 (8C1), and human CD4 (OKT4) were purchased from
Biolegend, eBioscience, or BD Biosciences. CCR7 staining was done at
37C prior to the addition of other antibodies per the manufacturer’s instruc-
tions (eBioscience). Samples were analyzed on an LSRII (Becton Dickinson)
or sorted on a FACSAria (Becton Dickinson) with doublet exclusion and DAPI
staining to remove dead cells when possible. Data were analyzed with
FlowJo (Tree Star).
TCR Sequencing
Sorted cell populations were frozen in Trizol (Life Technologies) prior to use.
RNA was isolated with an RNeasy mini kit (QIAGEN) and cDNA synthesized
withSuperScript III (Life Technologies). TCRVa2+ TCRswere amplifiedwith for-
ward primer 50-ATGGACAAGATCCTGACAGCA-30 and reverse primer 50-
TCAACTGGACCACAGCCTCAGC-30. TCR Va8+ TCRs were amplified with
the same reverse primer as above, but with a pair of forward primers: 50-ATGAA
CATGCGTCCTGACACCT-30 and 50- ATGAACATGCGTCCTGTCACCT-30.
PCR products were cloned into Zero Blunt TOPO (Life Technologies), trans-
duced into XL-10 Gold Ultracompetent Cells (Agilent Technologies), and
sequenced. TCR sequences were analyzed with IMGT (Lefranc et al., 2009).
Only in-frame TCR rearrangements were selected for retroviral expression.
To determine the overlap between TCRs scored as positive selection, nega-
tive selection, or non-selected and those found among wild-type splenocytes,
we obtained at least 350 Trav14 and Trav12 sequences derived from sorted
CD4+ or CD8+ T cells from pools of two Vb7 and two Vb8.2 transgenic mice.
Thymocyte Stimulation Cultures
Thymocytes from RV chimeras were depleted of CD69+ and PD-1+ cells by
AutoMACS to enrich for unsignaled DP thymocytes and 13 105 were cultured868 Immunity 43, 859–869, November 17, 2015 ª2015 Elsevier Inc.with either 2 3 104 MHC class I-expressing SV-40 transformed fibroblasts
derived from mice of eight different MHC haplotypes or with 5 3 105 cells
(2.5 3 105 thymocytes + 2.5 3 105 splenocyte) obtained from various mouse
strains as listed in the text and figures (Knowles et al., 1979). All cultures
were incubated for 18–24 hr in RPMI-10% FCS at 37C prior to analysis. After
incubation, cultures were harvested and CD69 and PD-1 expression were
examined on cells pre-gated for expression of thy1.1 (transduced cells) and
the RV-encoded TCR.
For experiments involving stimulation of WT or SOCE-deficient thymocytes,
53 105 DPCD69 cells were sorted and co-culturedwith 53 104 DCs isolated
as previously described (Inaba et al., 2009) in RPMI-10% FCS at 37C for 18 hr
in wells with or without plate-bound anti-TCRb antibody at 3 mg ml1.Statistical Analysis
Statistical analysis was performed in Prism (Graph Pad Software) via the un-
paired t test or Mann-Whitney test. If the groups that were compared had
significantly different variances (p < .05 by F test), Welch’s correction was
applied. *p < 0.05; **p < 0.01; ***p < 0.001.SUPPLEMENTAL INFORMATION
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